Learn how immunizing a critical portion of a community protects most members of the community.
Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.
Research to Advance Vaccine Safety (R01 and R21)
HIV Vaccines: Where We Are and Where We’re Headed
Vaccine Research Center (VRC) Boosts Research on Vaccines for HIV and Other Diseases
NIH Prepares to Launch 2009 H1N1 Influenza Vaccine Trial in People with Asthma—Oct. 9, 2009
NIH Launches 2009 H1N1 Influenza Vaccine Trials in HIV-Infected Children, Youth and Pregnant Women—Oct. 9, 2009
Bulletin: Early Results: NIAID Trial Supports Co-Administration of 2009 H1N1 Influenza Vaccine and Seasonal Influenza Vaccine—Oct. 9, 2009
NIAID Announces Vaccine Adjuvant Discovery Contracts—Oct. 8, 2009
NIAID Media Advisory: Update on NIAID Clinical Trials of 2009 H1N1 Influenza Vaccines in Children—Sept. 21, 2009
Statement: Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults—Sept. 11, 2009
All vaccine news and events
NIAID’s network of Vaccine and Treatment Evaluation Units (VTEUs).
Volunteer for NIAID-funded clinical studies related to vaccines on ClinicalTrials.gov.
View a list of links for more information about vaccines.
NIAID Publications order form
Order Publications